FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

703675000: Dapagliflozin propanediol (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2014. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3009016015 Dapagliflozin propanediol en Synonym Active Entire term case insensitive SNOMED CT core module
3009811014 Dapagliflozin propanediol (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dapagliflozin propanediol Is a Dapagliflozin false Inferred relationship Existential restriction modifier
Dapagliflozin propanediol Has disposition Sodium glucose cotransporter subtype 2 inhibitor true Inferred relationship Existential restriction modifier
Dapagliflozin propanediol Is modification of Dapagliflozin true Inferred relationship Existential restriction modifier
Dapagliflozin propanediol Is a Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely dapagliflozin propanediol 5 milligram/1 each conventional release oral tablet Has active ingredient False Dapagliflozin propanediol Inferred relationship Existential restriction modifier
Product containing precisely dapagliflozin propanediol 10 milligram/1 each conventional release oral tablet Has active ingredient False Dapagliflozin propanediol Inferred relationship Existential restriction modifier
Product containing precisely dapagliflozin propanediol 5 milligram/1 each conventional release oral tablet Has active ingredient False Dapagliflozin propanediol Inferred relationship Existential restriction modifier 1
Product containing precisely dapagliflozin propanediol 5 milligram/1 each conventional release oral tablet Has basis of strength substance False Dapagliflozin propanediol Inferred relationship Existential restriction modifier 1
Product containing precisely dapagliflozin propanediol 10 milligram/1 each conventional release oral tablet Has active ingredient False Dapagliflozin propanediol Inferred relationship Existential restriction modifier 1
Product containing precisely dapagliflozin propanediol 10 milligram/1 each conventional release oral tablet Has basis of strength substance False Dapagliflozin propanediol Inferred relationship Existential restriction modifier 1
Product containing precisely dapagliflozin propanediol 5 milligram/1 each conventional release oral tablet Has precise active ingredient False Dapagliflozin propanediol Inferred relationship Existential restriction modifier 1
Product containing precisely dapagliflozin propanediol 10 milligram/1 each conventional release oral tablet Has precise active ingredient False Dapagliflozin propanediol Inferred relationship Existential restriction modifier 1
Dapagliflozin propanediol monohydrate Is modification of True Dapagliflozin propanediol Inferred relationship Existential restriction modifier
Product containing precisely dapagliflozin (as dapagliflozin propanediol monohydrate) 5 milligram/1 each conventional release oral tablet (clinical drug) Has basis of strength substance False Dapagliflozin propanediol Inferred relationship Existential restriction modifier 1
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 10 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Dapagliflozin propanediol Inferred relationship Existential restriction modifier 1
Product containing precisely dapagliflozin (as dapagliflozin propanediol) 5 milligram/1 each conventional release oral tablet (clinical drug) Has precise active ingredient True Dapagliflozin propanediol Inferred relationship Existential restriction modifier 1
Dapagliflozin propanediol monohydrate Is a True Dapagliflozin propanediol Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Waymade Healthcare Plc) Has active ingredient False Dapagliflozin propanediol Inferred relationship Existential restriction modifier
Forxiga 5mg tablets (Waymade Healthcare Plc) Has active ingredient False Dapagliflozin propanediol Inferred relationship Existential restriction modifier
Dapagliflozin propanediol monohydrate Is a False Dapagliflozin propanediol Inferred relationship Existential restriction modifier
Forxiga 10mg tablets (Pharmaram Ltd) Has basis of strength substance True Dapagliflozin propanediol Inferred relationship Existential restriction modifier 1
Forxiga 10mg tablets (Pharmaram Ltd) Has precise active ingredient True Dapagliflozin propanediol Inferred relationship Existential restriction modifier 1
Dapagliflozin 10mg tablets 30 tablet Has basis of strength substance True Dapagliflozin propanediol Inferred relationship Existential restriction modifier 1
Dapagliflozin 10mg tablets 30 tablet Has precise active ingredient True Dapagliflozin propanediol Inferred relationship Existential restriction modifier 1
Forxiga 10mg tablets (Pharmaram Ltd) 28 tablet Has basis of strength substance True Dapagliflozin propanediol Inferred relationship Existential restriction modifier 1
Forxiga 10mg tablets (Pharmaram Ltd) 28 tablet Has precise active ingredient True Dapagliflozin propanediol Inferred relationship Existential restriction modifier 1
Forxiga 10mg tablets (Pharmaram Ltd) 30 tablet Has basis of strength substance True Dapagliflozin propanediol Inferred relationship Existential restriction modifier 1
Forxiga 10mg tablets (Pharmaram Ltd) 30 tablet Has precise active ingredient True Dapagliflozin propanediol Inferred relationship Existential restriction modifier 1

This concept is not in any reference sets

Back to Start